Pro-angiogenic properties of orosomucoid (ORM)

Experimental Cell Research

Volumn 315, Issue 18, 2009, Pages 3201-3209

  Irmak, Ster ^a   Oliveira Ferrer, Leticia ^b   Singer, Bernhard B ^a   Ergün, Süleyman ^a   Tilki, Derya ^c  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Angiogenesis; Endothelial cells; Human; Migration assay; Tube assay

Indexed keywords

OROSOMUCOID; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD CELL COUNT; CELL MIGRATION; CELL PROLIFERATION; CHICKEN; CHORIOALLANTOIS; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; REGULATORY MECHANISM; TISSUE SECTION;

EID: 70349782391     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.07.024     Document Type: Article

References (41)

1. K. Schmid, J. Am. Chem. Soc. 72 (1950) 2816.
2. Bennett M., and Schmid K. Immunosuppression by human plasma alpha 1-acid glycoprotein: importance of the carbohydrate moiety. Proc. Natl. Acad. Sci. U. S. A. 77 (1980) 6109-6113
3. K. Schmid in Putman, F.W.Y (Ed.), Academic Press, New York, (1975).
4. De Graaf T.W., Van der Stelt M.E., Anbergen M.G., and van D.W. Inflammation-induced expression of sialyl Lewis X-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera. J. Exp. Med. 177 (1993) 657-666
5. Fournier T., Medjoubi N., and Porquet D. Alpha-1-acid glycoprotein. Biochim. Biophys. Acta 1482 (2000) 157-171
6. Alam T., An M.R., Mifflin R.C., Hsieh C.C., Ge X., and Papaconstantinou J. trans-activation of the alpha 1-acid glycoprotein gene acute phase responsive element by multiple isoforms of C/EBP and glucocorticoid receptor. J. Biol. Chem. 268 (1993) 15681-15688
7. Baumann H., Prowse K.R., Marinkovic S., Won K.A., and Jahreis G.P. Stimulation of hepatic acute phase response by cytokines and glucocorticoids. Ann. N.Y. Acad. Sci. 557 (1989) 280-295 discussion
8. Baumann H., and Gauldie J. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol. Biol. Med. 7 (1990) 147-159
9. Lasky L.A. Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science 258 (1992) 964-969
10. Curry F.E., and Michel C.C. A fiber matrix model of capillary permeability. Microvasc. Res. 20 (1980) 96-99
11. Haraldsson B., and Rippe B. Orosomucoid as one of the serum components contributing to normal capillary permselectivity in rat skeletal muscle. Acta Physiol. Scand. 129 (1987) 127-135
12. Curry F.E., Rutledge J.C., and Lenz J.F. Modulation of microvessel wall charge by plasma glycoprotein orosomucoid. Am. J. Physiol. 257 (1989) H1354-H1359
13. Schnitzer J.E., and Pinney E. Quantitation of specific binding of orosomucoid to cultured microvascular endothelium: role in capillary permeability. Am. J. Physiol. 263 (1992) H48-H55
14. Muchitsch E.M., Teschner W., Linnau Y., and Pichler L. In vivo effect of alpha 1-acid glycoprotein on experimentally enhanced capillary permeability in guinea-pig skin. Arch. Int. Pharmacodyn. Ther. 331 (1996) 313-321
15. Johnsson E.K., and Haraldsson B.S. Addition of purified orosomucoid preserves the glomerular permeability for albumin in isolated perfused rat kidneys. Acta Physiol. Scand. 147 (1993) 1-8
16. Haraldsson B., Johnsson E.K., and Rippe B. Glomerular permselectivity is dependent on adequate serum concentrations of orosomucoid. Kidney Int. 41 (1992) 310-316
17. Pichler L., Muchitsch E.M., and Schwarz H.P. Preclinical investigation of alpha 1-acid glycoprotein (orosomucoid). Wien. Klin. Wochenschr. 111 (1999) 192-198
18. Predescu D., Predescu S., McQuistan T., and Palade G.E. Transcytosis of alpha1-acidic glycoprotein in the continuous microvascular endothelium. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 6175-6180
19. Levick J.R. Fluid exchange across endothelium. Int. J. Microcirc. Clin. Exp. 17 (1997) 241-247
20. Rippe B., and Haraldsson B. Transport of macromolecules across microvascular walls: the two-pore theory. Physiol. Rev. 74 (1994) 163-219
21. Sorensson J., Ohlson M., Bjornson A., and Haraldsson B. Orosomucoid has a cAMP-dependent effect on human endothelial cells and inhibits the action of histamine. Am. J. Physiol. Heart Circ. Physiol. 278 (2000) H1725-H1731
22. Ergun S., Tilki D., Hohn H.P., Gehling U., and Kilic N. Potential implications of vascular wall resident endothelial progenitor cells. Thromb. Haemost. 98 (2007) 930-939
23. Folkman J. Angiogenesis and apoptosis. Semin. Cancer Biol. 13 (2003) 159-167
24. Hanahan D., and Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86 (1996) 353-364
25. Rafii S., Lyden D., Benezra R., Hattori K., and Heissig B. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?. Nat. Rev. Cancer 2 (2002) 826-835
26. Ferrara N. VEGF as a therapeutic target in cancer. Oncology 69 Suppl 3 (2005) 11-16
27. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
28. Ergun S., Kilik N., Ziegeler G., Hansen A., Nollau P., Gotze J., Wurmbach J.H., Horst A., Weil J., Fernando M., and Wagener C. CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor. Mol. Cell 5 (2000) 311-320
29. Oliveira-Ferrer L., Tilki D., Ziegeler G., Hauschild J., Loges S., Irmak S., Kilic E., Huland H., Friedrich M., and Ergun S. Dual role of carcinoembryonic antigen-related cell adhesion molecule 1 in angiogenesis and invasion of human urinary bladder cancer. Cancer Res. 64 (2004) 8932-8938
30. Pepper M.S., Belin D., Montesano R., Orci L., and Vassalli J.D. Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J. Cell Biol. 111 (1990) 743-755
31. Schmidt N.O., Westphal M., Hagel C., Ergun S., Stavrou D., Rosen E.M., and Lamszus K. Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. Int. J. Cancer 84 (1999) 10-18
32. Iruela-Arispe M.L., Lane T.F., Redmond D., Reilly M., Bolender R.P., Kavanagh T.J., and Sage E.H. Expression of SPARC during development of the chicken chorioallantoic membrane: evidence for regulated proteolysis in vivo. Mol. Biol. Cell 6 (1995) 327-343
33. Ribatti D., Gualandris A., Bastaki M., Vacca A., Iurlaro M., Roncali L., and Presta M. New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: the gelatin sponge/chorioallantoic membrane assay. J. Vasc. Res. 34 (1997) 455-463
34. Sorensson J., Matejka G.L., Ohlson M., and Haraldsson B. Human endothelial cells produce orosomucoid, an important component of the capillary barrier. Am. J. Physiol. 276 (1999) H530-H534
35. Irmak S., Tilki D., Heukeshoven J., Oliveira-Ferrer L., Friedrich M., Huland H., and Ergun S. Stage-dependent increase of orosomucoid and zinc-alpha2-glycoprotein in urinary bladder cancer. Proteomics 5 (2005) 4296-4304
36. Ausprunk D.H., Knighton D.R., and Folkman J. Differentiation of vascular endothelium in the chick chorioallantois: a structural and autoradiographic study. Dev. Biol. 38 (1974) 237-248
37. Boncela J., Papiewska I., Fijalkowska I., Walkowiak B., and Cierniewski C.S. Acute phase protein alpha 1-acid glycoprotein interacts with plasminogen activator inhibitor type 1 and stabilizes its inhibitory activity. J. Biol. Chem. 276 (2001) 35305-35311
38. Hashizume H., Baluk P., Morikawa S., McLean J.W., Thurston G., Roberge S., Jain R.K., and McDonald D.M. Openings between defective endothelial cells explain tumor vessel leakiness. Am. J. Pathol. 156 (2000) 1363-1380
39. Duche J.C., Urien S., Simon N., Malaurie E., Monnet I., and Barre J. Expression of the genetic variants of human alpha-1-acid glycoprotein in cancer. Clin. Biochem. 33 (2000) 197-202
40. Kilic N., Oliveira-Ferrer L., Wurmbach J.H., Loges S., Chalajour F., Neshat-Vahid S., Weil J., Fernando M., and Ergun S. Pro-angiogenic signaling by the endothelial presence of CEACAM1. J. Biol. Chem. 280 (2005) 2361-2369
41. Kilic N., Oliveira-Ferrer L., Neshat-Vahid S., Irmak S., Obst-Pernberg K., Wurmbach J.H., Loges S., Kilic E., Weil J., Lauke H., Tilki D., Singer B.B., and Ergun S. Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Prox1. Blood 110 (2007) 4223-4233